dermaPACE System
Extracorporeal Shock Wave Device For Treatment Of Diabetic Foot Ulcers. De Novo DEN160037, from Sanuwave, Inc. (Alpharetta, GA). Product code PZL, class 2.
As of Nov 20, 2026, DEN160037 is an FDA De Novo held by Sanuwave, Inc., granted on Dec 28, 2017 after 521 days, with no recalls tied to it in FDA's recall database.
- Review time: 521 days
- Recalls: 0
- Cited as a predicate by: 2 devices
The SANUWAVE dermaPACE System is indicated to provide acoustic pressure shockwaves in the treatment of chronic, full-thickness diabetic foot ulcers with wound areas measuring no larger than 16 cm2, which extend through the epidermis, dermis, tendon, or capsule, but without bone exposure.
- Design
- Prospective, randomized, double-blind, sham-controlled, multicenter 24-week study (Study 1) of dermaPACE plus standard of care
- Enrolled
- 206
- Where
- 24 sites, US, England, Germany
- Primary endpoint
- Complete wound closure at 12 weeks post-initial application; primary safety endpoint: rate of adverse events through 24 weeks
- Result
- Not met: 20.6% dermaPACE vs 15.2% sham at 12 weeks (p=0.363); AE rate 80.4% vs 78.8% (p=0.725)
- Storz Medical Duolith SD1 T-Top & Tower System with C-Actor Sepia HandpieceK202112 · Storz Medical AG · Feb 21, 2021
- OrthoGoldK191961 · Tissue Regeneration Technologies · Nov 26, 2019
- DOLORCLAST Focused Shock WavesK243279 · E.M.S Electro Medical Systems S.A · Aug 13, 2025
- CS-Pro MEDK250779 · Curative Sound Therapeutics · Jul 2, 2025
- OW100SK233937 · Softwave/Trt, LLC · Jul 9, 2024
- OW100SK231710 · Softwave/Trt, LLC · Sep 1, 2023
- Storz Medical Duolith SD1 T-Top & Tower System with C-Actor Sepia HandpieceK202112 · Storz Medical AG · Feb 21, 2021
- Document
- De Novo decision summary (PDF) ↗
- Type
- Direct
- Received
- Jul 25, 2016
- Review panel
- General, Plastic Surgery
- Regulation
- 21 CFR 878.4685
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files